Literature DB >> 11773599

Phenotypic variations of orpk mutation and chromosomal localization of modifiers influencing kidney phenotype.

C Sommardahl1, M Cottrell, J E Wilkinson, R P Woychik, D K Johnson.   

Abstract

The Oak Ridge polycystic kidney (orpk) mutant mouse model resulted from a transgene insertion into the Tg737 gene and exhibits a pleiotropic syndrome with lesions in the kidney, liver, and pancreas. We found marked differences in the phenotypic expression of the orpk mutation when bred on different genetic backgrounds. In the FVB/N background, the phenotype is very severe for kidney, pancreas, and liver lesions. To evaluate better how genetic background might influence the expressivity of the orpk phenotype, we bred the transgene into the C3HeB/FeJLe (C3H) genetic background. We performed a genome-wide scan using backcross and intercross populations with more than 150 markers to map the chromosomal location of the modifier genes that differ in the FVB/N and C3H genetic backgrounds that affect the severity of kidney disease in the orpk mouse. Low-resolution interval mapping was performed using the Map Manager QTb program, with the interval explaining a significant portion of the variance being the distal end of chromosome 4.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11773599     DOI: 10.1152/physiolgenomics.00089.2001

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  5 in total

1.  Telomerase immortalization of principal cells from mouse collecting duct.

Authors:  Stacy L Steele; Yongren Wu; Robert J Kolb; Monika Gooz; Courtney J Haycraft; Kent T Keyser; Lisa Guay-Woodford; Hai Yao; P Darwin Bell
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-06

Review 2.  The Oak Ridge Polycystic Kidney mouse: modeling ciliopathies of mice and men.

Authors:  Jonathan M Lehman; Edward J Michaud; Trenton R Schoeb; Yesim Aydin-Son; Michael Miller; Bradley K Yoder
Journal:  Dev Dyn       Date:  2008-08       Impact factor: 3.780

3.  Inhibition of Comt with tolcapone slows progression of polycystic kidney disease in the more severely affected PKD/Mhm (cy/+) substrain of the Hannover Sprague-Dawley rat.

Authors:  Susanne N E Boehn; Sonja Spahn; Sabine Neudecker; Andrea Keppler; Marie-Thérèse Bihoreau; Bettina Kränzlin; Priyanka Pandey; Sigrid C Hoffmann; Li Li; Vicente E Torres; Hermann-Josef Gröne; Norbert Gretz
Journal:  Nephrol Dial Transplant       Date:  2013-03-29       Impact factor: 5.992

4.  Investigating the effect of genetic background on proteinuria and renal injury using two hypertensive strains.

Authors:  Matthew Packard; Yasser Saad; William T Gunning; Shalini Gupta; Joseph Shapiro; Michael R Garrett
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-28

5.  The fate of bone marrow-derived cells carrying a Polycystic Kidney Disease mutation in the genetically normal kidney.

Authors:  Elizabeth Verghese; Chad Johnson; John F Bertram; Sharon D Ricardo; James A Deane
Journal:  BMC Nephrol       Date:  2012-08-29       Impact factor: 2.388

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.